Aroca Del Pinar Socimi Stock Quote MLARO - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Europe
EU
Aroca Del Pinar Socimi SA (MLARO) Quote

Aroca Del Pinar Socimi SA (MLARO)

0.00

0.00

( 0.00% )

Updated: -

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

-

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

0.00

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

5,000,187

Dividend Yield

-

PE Ratio

0.00

Earnings Per Share (EPS)

-

Revenue

7.89M

Net Profit

7.81M

Sector

Real Estate Investment Trust

Industry

Real Estate Investment Trust

Website

arocadelpinarsocimi.es

Headquarters

Madrid, Community Of Madrid, Esp

Founded

-

Aroca Del Pinar Socimi SA is listed in the Real Estate Investment Trust sector of the Euronext with ticker MLARO. The last closing price for Aroca Del Pinar Socimi was 0.00 €. Over the last year, Aroca Del Pinar Socimi shares have traded in a share price range of 0.00 € to 0.00 €.

Aroca Del Pinar Socimi currently has 5,000,187 shares outstanding.

Aroma Celte : partenaire officiel du maillot d'En Avant de Guingamp

Communiqué de presseSaint-Agathon, le 18 mai 2016 Aroma Celte partenaire officiel du maillot d'En Avant de Guingamp Aroma Celte® soutient l'équipe de football de première ligue...

Aroma Celte : Entrée en Bourse réussie sur le Marché Libre d'Euronext Paris

Communiqué de Presse Saint Agathon, le 19 décembre 2014 Entrée en Bourse réussie d'AROMA CELTE sur le Marché Libre d'Euronext...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALNEVNeovacs	0.0003 € (50.00%)	14.89M
ALMDPMedesis Pharma SA	0.56 € (37.93%)	47.91k
ALNMGNetMedia Group	2.408 € (36.05%)	6.96k
CNVCnova NV	0.13 € (26.83%)	1.09k
DMSBSDiagnostic Medical Systems	0.0025 € (25.00%)	1.9k
ALAVEAventador	0.0012 € (-33.33%)	30.74M
VACBSPierre & Vacances	0.0562 € (-21.94%)	4.94k
NYRNyrstar NV	0.125 € (-13.79%)	145.05k
ALREARealites	2.13 € (-8.19%)	1.13k
OXUROxurion NV	0.282 € (-7.54%)	10.01k
ALAVEAventador	0.0012 € (-33.33%)	30.74M
ALNEVNeovacs	0.0003 € (50.00%)	14.89M
BCPBanco Comercial Portugues SA	0.4599 € (-0.69%)	7.93M
LATLatecoere	0.0067 € (0.00%)	4.14M
ALDRVDrone Volt	0.004 € (0.00%)	3.37M

bernice

bernice 8 minutes ago

I think the reason is: something is behind the bush now and not in September.

JamesLH

JamesLH 11 minutes ago

Little Ricki crying yet again that he can't stop the whistle-blowers from exposing this FRAUD. Why don't you go make the same fake police report you conman CEO Nick Campanella claims he did?

Let's see how quickly you get laughed and thrown out of the police station! LMFAO

marcis

marcis 17 minutes ago

No, here is ok but, admittedly spinning BS, without owning is, plain wrong.

The gap off an outdated irrelevant chart before the merger announcement

You cannot show RDAR is in default

And this upper level people you refer to is hilariously not here or sh

tkg

tkg 19 minutes ago

The growth of data center CapEx is expected to be driven by the deployment of new data centers by cloud, colocation, and telco service providers, as well as enterprise data center modernization. Some predict that data center CapEx could top $1 trillion by 2027 due to the growth of artificial intelli

cottonisking

cottonisking 19 minutes ago

🌍️🌍️🗺️ This World is all jacked up right now! UNBELIEVABLE, it only took him four years.

wagner

wagner 19 minutes ago

Might someone have an idea?

The new money infussion is used to pay Marks loan 2 million back

Why not in September taken the placement?

Mark gets money, anyway

either way too stupid or unable to plan

sharing4u

sharing4u 21 minutes ago

style="font-size: 16px"Here are the top 7 partnerships and joint ventures of JP3E:
style="font-size: 16px"

style="font-size: 16px"*US Partnerships*
style="font-size: 16px"

style="font-size: 16px"1. *JP3E ExxonMobil Energy Partners*

snow

snow 24 minutes ago

I ll be back Your statements are very dubious. I have found the following googling MOU: "Our partners often ask us to explain the difference
between a contract and a memorandum of
understanding (MOU). Although there can be legal
distinctions between the two types of documents,

DocLee

DocLee 33 minutes ago

Droid - You really are an infantile Wally trying that hopeless line of argument.

sharing4u

sharing4u 36 minutes ago

style="font-size: 16px"Here are the details relating to JP3E and ArcLight Capital Partners joint ventures:
style="font-size: 16px"

style="font-size: 16px"*JP3E Energy Partners LLC*
style="font-size: 16px"

style="font-size: 16px"- In

Ribo

Ribo 38 minutes ago

$IDVV Change in Control
https://www.otcmarkets.com/otcapi/company/financial-report/414724/content

sharing4u

sharing4u 39 minutes ago

Focus seeking help from AI search was not on accuracy but for a general vscope about business coverage and foot print in US and worldwide.
How big how wide is JP3E ?

Batman412

Batman412 40 minutes ago

Big buys coming all week mark it

sharing4u

sharing4u 48 minutes ago

This is trying to answer the following questions:

A. Any affiliation or partnership between JP3E (JP 3E Holdings Inc.) and ArcLight Capital Partners ?

B. How BIG is JP3E relating to US and global style="font-size: 1em"business ?

Believe it or not.

dennisdave

dennisdave 49 minutes ago

mmmmm

DCVAXL trial
Median OS (mOS) for the 232 patients with nGBM receiving DCVax-L was 19.3 (95% CI, 17.5-21.3) months

SurVaxM is an experimental vaccine for the treatment of brain tumors. Early results from a small trial were recently reported Of 63 patients

GVInvestments

GVInvestments 55 minutes ago

How until they Hit $300 per share? I really want 300 per share.

Truthsocial

Truthsocial 1 hour ago

You are hitting the nail right on the head spot on ...facts are facts
Seems most so called Conspiracy theories have come to be true Facts...that's a Fact

misterfishman

misterfishman 1 hour ago

I kid you not i. Can still bench 225 because of it.your going to want to take Dimm with it to block estrogen cause it will increase that as well.

PC retired

PC retired 1 hour ago

Dania?, do you mean Denmark?

go seek

go seek 1 hour ago

Judge Denise J.Casper is the judge on the Paxlovid lawsuit. Her husband is Marc Casper, CEO of Thermo Fisher Scientific.
Goggle ‘Thermo Fisher Scientific Pfizer’… There could be a conflict of interest here.

Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access t

TheOTCstocksGuy

TheOTCstocksGuy 1 hour ago

Headed under .50 and lower! Watch and learn...

rx7171

rx7171 1 hour ago

Since sleep improvement is neither a primary or secondary trial endpoint we should not expect precise data with a p value.

Hoghead7

Hoghead7 1 hour ago

Check this out!
https://www.linkedin.com/posts/mark-labarbera-4230924a_working-closely-with-our-partners-at-toyota-activity-7244686263331557377-I8YD?utm_source=share&utm_medium=member_android

Aroca Del Pinar Socimi

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions